SCHEMBL7666411

SCHEMBL7666411

COc1cc(Oc2ccc(Br)cc2Br)c2c(c1)C(=O)CCN2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 3/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ TSHR P16473 1/20 0.38
▸ ACHE P22303 1/20 0.37
▸ MEN1 O00255 3/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ LMNA P02545 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ HPGD P15428 2/20 0.36
▸ HTT P42858 2/20 0.36
▸ ATM Q13315 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ ALOX15 P16050 4/20 0.35
▸ PARP10 Q53GL7 2/20 0.35
▸ PARP11 Q9NR21 1/20 0.35
▸ PARP1 P09874 1/20 0.35
▸ HTR2A P28223 1/20 0.33
▸ HTR2C P28335 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8188963 0.82 ACHE (0.47) MAPK1L3MBTL1ALDH1A1ACHEMEN1
SCHEMBL8221443 0.73 MEN1 (0.44) MAPK1L3MBTL1ALDH1A1ACHEMEN1
SCHEMBL5399245 0.70 MEN1 (0.50) MAPK1L3MBTL1ALDH1A1MEN1KMT2A
SCHEMBL9035419 0.70 ACHE (0.46) MAPK1L3MBTL1ALDH1A1ACHEMEN1
SCHEMBL9036456 0.66 ACHE (0.42) MAPK1L3MBTL1ALDH1A1ACHEMEN1
SCHEMBL29469601 0.66 MAPK1 (0.71) MAPK1L3MBTL1ALDH1A1TDP1TSHR
SCHEMBL28687305 0.66 ALDH1A1 (0.49) MAPK1ALDH1A1TSHRMEN1KMT2A
SCHEMBL29948190 0.66 ALDH1A1 (0.49) MAPK1ALDH1A1TSHRMEN1KMT2A
SCHEMBL899494 0.65 MAPK1 (1.00) MAPK1L3MBTL1ALDH1A1TDP1TSHR
SCHEMBL29367556 0.65 MAPK1 (1.00) MAPK1L3MBTL1ALDH1A1TDP1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6476021-B1 Compounds having cGMP-PDE inhibitory effect MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2002-11-05 — — US disclosed
EP-1048666-A1 NOVEL COMPOUNDS HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-11-02 — — EP disclosed
Send feedback